CONy 2023 | Stroke & epilepsy debates at CONy 2023

Amos Korczyn, MD, Tel Aviv University, Tev Aviv, Israel, describes the debates that will take place during the 17th World Congress on Controversies in Neurology (CONy). The epilepsy discussions will cover topics such as levetiracetam as the drug of choice, the increased risk of depression of antiseizure medications, and if only drugs with substantial advantages in seizure control should be approved in the future. In the stroke debates, experts will discuss if reversal agents should be used to allow IV thrombolytics to be given to people with acute ischemic stroke who are taking direct oral anticoagulants, if intraarterial thrombolytics should be routinely administered after mechanical thrombectomy, the benefit of cholesterol-lowering strategies in people with non-atherosclerotic stroke, and the differences in the delivery of stroke treatments between men and women. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.